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Acne inversa · Locations · Phenotype
Dear Editor, 
Recently, a cross-sectional study assessing the associa-
tions between patient characteristics and affected loca-
tions in patients with hidradenitis suppurativa (HS) was 
published in Dermatology by Benhadou et al. [1].
We acknowledge the importance of this work. How-
ever, we argue that the results might not be as readily in-
terpretable as suggested by the authors. The authors rec-
ognize the influence of sex on the distribution of HS le-
sions and touch upon the difference in clinical phenotypes 
between the sexes [2]. Nonetheless, there are more rea-
sons to assume that HS manifests differently in men and 
women. First, the prevalence of HS differs greatly be-
tween the sexes; 137 per 100,000 (95% CI, 136–139 per 
100,000) in women compared with 58 per 100,000 (95% 
CI, 57–59 per 100,000) in men [3]. Second, a subgroup of 
women are known to experience peri-menstrual HS flares 
and oral contraceptives can relieve HS symptoms in these 
patients [4, 5]. Based on this knowledge, it is conceivable 
that part of the pathophysiology could differ between the 
sexes and related predisposing factors might have a dif-
ferent effect in men and women. Therefore, the degree 
and possibly even the direction of the associations be-
tween patient characteristics and the affected locations 
might be different for men and women. We argue that 
assessing the association of patient characteristics with 
affected locations separately for men and women could 
lead to valuable new insights. 
Moreover, the authors state that their results are in 
favour of regional associations, for example for the but-
tocks, subgluteal, and anal regions. However, the associa-
tions found between these and other neighbouring re-
gions might be more suggestive of a lack of clear definitions 
of these regions, as briefly mentioned by the authors in the 
discussion. Moreover, several regions, e.g., the “subglu-
teal” region, are not commonly counted as separate enti-
ties in clinical HS trials or daily practice. In light of the lack 
of clearly defined anatomical regions for the scoring of HS 
and the use of non-standard body areas in this study, it 
would be of added value to know whether all patients were 
scored by the same or by different physicians. In addition, 
it would be of interest to combine these difficult to distin-
guish regions into more accepted anatomical regions and 
see what independent associations remain [6].
The authors have performed elaborate multivariate 
analyses. However, it should be noted that Hurley stage is 
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a categorical variable which will result in different odds 
for the different Hurley stages in the logistic regression 
models. Therefore, we suggest specifying the odds for 
Hurley stage II and III (with Hurley stage I as the refer-
ence category) for each location. 
In conclusion, we commend the authors for their ex-
tensive research on the association between patient char-
acteristics and affected locations in a large sample of HS 
patients. Nonetheless, the results need to be interpreted 
with care as they are subject to a lack of clearly defined 
anatomical regions and possible interrater variability. As-
sessing the association between patient characteristics 
and affected regions could lead to valuable new insights 
and shed more light on the differences between the sexes 
in patients with HS.
Key Message
Separately assessing associations of patient characteristics with 
affected locations for the sexes could provide valuable insights.
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